| International scoring system for evaluating prognosis in myelodysplastic syndromes P Greenberg, C Cox, MM LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, ... Blood, The Journal of the American Society of Hematology 89 (6), 2079-2088, 1997 | 5530 | 1997 |
| Revised international prognostic scoring system for myelodysplastic syndromes PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F Solé, ... Blood, The Journal of the American Society of Hematology 120 (12), 2454-2465, 2012 | 3295 | 2012 |
| Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study P Fenaux, GJ Mufti, E Hellstrom-Lindberg, V Santini, C Finelli, ... The lancet oncology 10 (3), 223-232, 2009 | 2981 | 2009 |
| Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia BD Cheson, PL Greenberg, JM Bennett, B Lowenberg, PW Wijermans, ... Blood 108 (2), 419-425, 2006 | 1800 | 2006 |
| Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia V Rocha, M Labopin, G Sanz, W Arcese, R Schwerdtfeger, A Bosi, ... New England Journal of Medicine 351 (22), 2276-2285, 2004 | 1237 | 2004 |
| Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia P Fenaux, GJ Mufti, E Hellström-Lindberg, V Santini, N Gattermann, ... Journal of clinical oncology 28 (4), 562-569, 2010 | 1162 | 2010 |
| Report of an international working group to standardize response criteria for myelodysplastic syndromes BD Cheson, JM Bennett, H Kantarjian, A Pinto, CA Schiffer, SD Nimer, ... Blood, The Journal of the American Society of Hematology 96 (12), 3671-3674, 2000 | 914 | 2000 |
| Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet L Malcovati, E Hellström-Lindberg, D Bowen, L Adès, J Cermak, ... Blood, The Journal of the American Society of Hematology 122 (17), 2943-2964, 2013 | 791 | 2013 |
| Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis M Eapen, V Rocha, G Sanz, A Scaradavou, MJ Zhang, W Arcese, ... The lancet oncology 11 (7), 653-660, 2010 | 649 | 2010 |
| Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System H Kantarjian, S O'Brien, F Ravandi, J Cortes, J Shan, JM Bennett, A List, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 578 | 2008 |
| A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q P Fenaux, A Giagounidis, D Selleslag, O Beyne-Rauzy, G Mufti, ... Blood, The Journal of the American Society of Hematology 118 (14), 3765-3776, 2011 | 558 | 2011 |
| Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 … GF Sanz, MA Sanz, T Vallespi, MC Canizo, M Torrabadella, S Garcia, ... | 510 | 1989 |
| Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice E Gluckman, V Rocha, W Arcese, G Michel, G Sanz, KW Chan, ... Experimental hematology 32 (4), 397-407, 2004 | 503 | 2004 |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 455 | 2020 |
| Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the … GJ Mufti, JM Bennett, J Goasguen, BJ Bain, I Baumann, R Brunning, ... haematologica 93 (11), 1712-1717, 2008 | 405 | 2008 |
| Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022 | 392 | 2022 |
| Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel T De Witte, D Bowen, M Robin, L Malcovati, D Niederwieser, ... Blood, The Journal of the American Society of Hematology 129 (13), 1753-1762, 2017 | 361 | 2017 |
| Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia E Such, U Germing, L Malcovati, J Cervera, A Kuendgen, MG Della Porta, ... Blood, The Journal of the American Society of Hematology 121 (15), 3005-3015, 2013 | 344 | 2013 |
| Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia C Elena, A Galli, E Such, M Meggendorfer, U Germing, E Rizzo, J Cervera, ... Blood, The Journal of the American Society of Hematology 128 (10), 1408-1417, 2016 | 315 | 2016 |
| One-unit versus two-unit cord-blood transplantation for hematologic cancers JE Wagner Jr, M Eapen, S Carter, Y Wang, KR Schultz, DA Wall, N Bunin, ... New England Journal of Medicine 371 (18), 1685-1694, 2014 | 311 | 2014 |
